Thalidomide-NH-amido-C4-NH2 is primarily utilized in the field of medicinal chemistry and drug development. It is often employed as a key intermediate in the synthesis of more complex molecules, particularly those targeting specific biological pathways. Its structure allows for modifications that can enhance binding affinity to therapeutic targets, making it valuable in the design of novel pharmaceuticals. This compound is frequently explored in the development of anti-cancer agents, as its derivatives can inhibit angiogenesis, thereby restricting tumor growth. Additionally, it is studied for its potential immunomodulatory effects, which could be beneficial in treating autoimmune diseases. Researchers also investigate its role in creating targeted drug delivery systems, where its functional groups can be tailored to improve specificity and reduce off-target effects. Overall, it serves as a versatile building block in the creation of advanced therapeutic agents.